Λοιμωξιολογία Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study 16/12/2024 time to read 3 min read
Λοιμωξιολογία Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 21/12/2023 time to read 2 min read
Λοιμωξιολογία Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial 03/07/2023 time to read 2 min read
Λοιμωξιολογία A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study) Authors: Ivan Titov et al 06/12/2021 time to read 2 min read
HIV Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial Authors: Chloe Orkin et al. 01/07/2021 time to read 2 min read
Λοιμωξιολογία RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections Authors: Johann Motsch et al. 15/04/2020 time to read 2 min read
HIV Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial Authors: Jean-Michel Molina et al. 01/01/2020 time to read 3 min read
Λοιμωξιολογία Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial Authors: Marin H Kollef et al. 01/12/2019 time to read 2 min read
HIV Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial Authors: Chloe Orkin et al. 01/02/2019 time to read 2 min read
HIV Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial Authors: Jean-Michel Molina et al. 01/05/2018 time to read 3 min read
Λοιμωξιολογία Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation 21/12/2017 time to read 2 min read